Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2021
SpyBiotech raises $32.5 million in Series A financing
SpyBiotech announced it raised $32.5 million in Series A equity financing. The company said the proceeds will advance clinical development of its vaccine technology platform.
2021
SpyBiotech appoints Andre Crawford-Brunt to its board
SpyBiotech announced the appointment of Andre Crawford-Brunt, a general partner at Braavos Investment Advisers, to its board.
2021
SpyBiotech appoints Lutz B. Giebel as chairman
SpyBiotech announced the appointment of Lutz B. Giebel as chairman of its board. The company described the appointment as strengthening governance and oversight as it expands.